Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
Helen Morement(CRUK Lung Cancer Centre of Excellence), John Primrose(University of Southampton), Clive Stubbs(Cancer Research UK Clinical Trials Unit), Stephen Falk(At Bristol), Jonathan Wadsley(Weston Park Cancer Centre), Raaj Praseedom(Cambridge University Hospitals NHS Foundation Trust), Deborah Stocken(Cancer Research UK Clinical Trials Unit), U. Hombaiah(Southampton General Hospital), Daniel H. Palmer(Cancer Research UK Clinical Trials Unit), Tamas Hickish(Southampton General Hospital), Shihua Zhu(University of Southampton), Ian Pope(Southampton General Hospital), Chinenye Iwuji(Southampton General Hospital), JEFF EVANS(University of Glasgow), Brian R Davidson(The Royal Free Hospital), John P. Neoptolemos(University of Liverpool), Timothy Iveson(University Hospital Southampton NHS Foundation Trust), David Cunningham(Royal Marsden NHS Foundation Trust), Pippa Corrie(Cambridge University Hospitals NHS Foundation Trust), John Dent(Royal Adelaide Hospital), O. James Garden(University of Edinburgh), Yuk Ting(University Hospitals Birmingham NHS Foundation Trust), Harpreet Wasan(Peter MacCallum Cancer Centre), Tom Crosby(Southampton General Hospital), James Raftery(University of Southampton), Oscar S.H. Chan(Southampton General Hospital), Juan W. Valle(The Christie NHS Foundation Trust), Alan Anthoney(St James's University Hospital), John Bridgewater(University College Hospital), Paul J. Ross(Guy's and St Thomas' NHS Foundation Trust), Douglas Adamson(Southampton General Hospital), Rajendra Prasad(University of Leeds), Lucy Wall(NHS Lothian), K Sharkland(University Hospitals Birmingham NHS Foundation Trust), Ma Yt(University Hospitals Birmingham NHS Foundation Trust), Hassan Malik(University of Liverpool), Richard Fox(Cancer Research UK Clinical Trials Unit), RP Fox(Cancer Research UK Clinical Trials Unit), S. Sothi(Southampton General Hospital), C. Rees(Southampton General Hospital), Alan Anthony(Leeds Teaching Hospitals NHS Trust), Darius Mirza(NIHR Surgical Reconstruction and Microbiology Research Centre), Meg Finch-Jones(Bristol Royal Infirmary)
Cited by 1,220
Related Papers
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k